login
Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 

Endovascular treatment for diabetic foot syndrome shows nearly 83% freedom from amputation


Thursday, 20 Oct 2011 13:51

A study first published online on 12 September in the Journal of Interventional Cardiology suggests that endovascular treatment of diabetic foot syndrome using mixed coronary and peripheral materials and techniques leads to high immediate success and limb salvage rates compared to historical series.


Authors of the study, Paolo Cardaioli, department of Interventional Cardiology, University of Padova Medical School, Padova, Italy et al set out to assess the long-term results of interventional treatment of diabetic foot using mixed coronary and peripheral equipments and techniques.


A diabetic foot exhibits any pathology that results directly from diabetes mellitus or any chronic complication of diabetes mellitus. Presence of several characteristic diabetic foot pathologies is called diabetic foot syndrome. Interventional treatment for the diabetic foot is rapidly becoming the therapy of choice for patients, but proper materials and techniques are still debated, wrote the authors.


The investigators prospectively enrolled 220 diabetic patients (78.5±15.8 years, 107 female, all with Fontaine III or IV class) from January 2006 to December 2010 who were referred to our center for diabetic foot syndrome and severe limb ischaemia. They used techniques using both coronary and peripheral guidewires and balloons. Doppler ultrasonography and foot transcutaneous oxygen pressure (TcPO2) before and after the procedure were calculated as well as the amputation rate.


Cardaioli et al point out that the preferred approach was ipsilateral femoral antegrade in 170/220 patients (77.7%), contralateral cross-over in 40/220 patients (18.8%), and popliteal retrograde plus femoral antegrade in 10/220 patients (4.5%).


They explain that the techniques included combined use of coronary and dedicated peripheral guidewires and coronary and peripheral dedicated balloons. “Percutaneous balloon angioplasty was performed in 252 legs, and contributing to these were 32 patients with bilateral disease. The procedure was successful in 239/252 legs with an immediate success rate of 94.8% and a significant improvement in TcPO2 and ankle-brachial index with ulcer healing in 233/252 legs (92.4%).” Authors wrote that the freedom from major amputation was 82.8% at a mean follow-up of 3.1±1.8 years (range one to five years).




Add New Comment

Related Items


Most popular


Ultrasound-guided radiofrequency ablation results in significant volume reduction for benign thyroid nodules
Friday, 04 Mar 2016
Two studies presented at the European Congress of Radiology (2–6 March, Vienna, Austria) have found that radiofrequency ablation could have a role in the treatment of thyroid nodules. Ultrasound-guided radiofrequency ablation results in significant volume reduction for benign thyroid nodules

Interventional radiology treatment for frostbite
Thursday, 03 Mar 2016
A recent presentation shed light on catheter-directed intra-arterial thrombolysis for frostbite. The investigators urged interventional radiologists to become familiar with the current management of ... Interventional radiology treatment for frostbite

Monday, 14 Mar 2016
Although systemic thrombolysis achieves similar rates of mortality as catheter-directed intervention for the treatment of acute pulmonary embolism, it also carries “significantly increased odds of ... Systemic thrombolysis for acute pulmonary embolism increases stroke risk compared with catheter-directed intervention

Features


A research track record helps physicians assess new technology
Tuesday, 12 Apr 2016
Scott Trerotola, Stanley Baum Professor and chief, Vascular and Interventional Radiology, University of Pennsylvania Medical Center, Philadelphia, USA, delivered the Dr Charles T Dotter Lecture at ... A research track record helps physicians assess new technology

How we innovate must change dramatically
Friday, 01 Apr 2016
In order to fully capitalise on the potential of advances in materials, drugs, biologics, sensing, informatics, guidance, manufacturing processes and marketing, an organised collaborative approach to ... How we innovate must change dramatically

Profiles


Gabriel Bartal
Thursday, 26 Nov 2015
“In the early days, I used to have to cut a 7F plastic tube, make side holes, send it off for ... Gabriel Bartal

Lindsay Machan
Thursday, 28 May 2015
“Focusing on maximising rewards has sidelined more ideas than it has helped individual inventors. S... Lindsay Machan

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions